Sangamo Therapeutics Aktie
2,30
EUR
-0,50
EUR
-17,81
%
2,37
USD
+0,06
USD
+2,38
%
Sangamo Therapeutics Aktie Analyse
26.08.19 | Sangamo Therapeutics Buy | H.C. Wainwright & Co. | |
24.04.15 | Sangamo Therapeutics Outperform | BMO Capital Markets | |
08.10.09 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
26.08.09 | Sangamo Therapeutics market outperform | JMP Securities LLC | |
23.02.09 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
11.11.08 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
16.10.08 | Sangamo Therapeutics buy | Merriman Curhan Ford & Co | |
26.08.08 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
Werbung
|
|||
07.02.08 | Sangamo Therapeutics strong buy | JMP Securities | |
06.11.07 | Sangamo Therapeutics strong buy | JMP Securities | |
26.10.07 | Sangamo Therapeutics strong buy | JMP Securities | |
18.10.07 | Sangamo Therapeutics buy | Pacific Growth Equities | |
01.12.06 | Sangamo Therapeutics market outperform | JMP Securities | |
24.08.06 | Sangamo Therapeutics Buy | Cantor Fitzgerald |